288 related articles for article (PubMed ID: 30018118)
1. Vitamin D Supplementation and Survival of Patients with Non-small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial.
Akiba T; Morikawa T; Odaka M; Nakada T; Kamiya N; Yamashita M; Yabe M; Inagaki T; Asano H; Mori S; Tsukamoto Y; Urashima M
Clin Cancer Res; 2018 Sep; 24(17):4089-4097. PubMed ID: 30018118
[No Abstract] [Full Text] [Related]
2. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial.
Urashima M; Ohdaira H; Akutsu T; Okada S; Yoshida M; Kitajima M; Suzuki Y
JAMA; 2019 Apr; 321(14):1361-1369. PubMed ID: 30964526
[TBL] [Abstract][Full Text] [Related]
3. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.
Zhou W; Heist RS; Liu G; Asomaning K; Neuberg DS; Hollis BW; Wain JC; Lynch TJ; Giovannucci E; Su L; Christiani DC
J Clin Oncol; 2007 Feb; 25(5):479-85. PubMed ID: 17290055
[TBL] [Abstract][Full Text] [Related]
4. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer.
Heist RS; Zhou W; Wang Z; Liu G; Neuberg D; Su L; Asomaning K; Hollis BW; Lynch TJ; Wain JC; Giovannucci E; Christiani DC
J Clin Oncol; 2008 Dec; 26(34):5596-602. PubMed ID: 18936471
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients.
Zhou W; Heist RS; Liu G; Neuberg DS; Asomaning K; Su L; Wain JC; Lynch TJ; Giovannucci E; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2239-45. PubMed ID: 17119052
[TBL] [Abstract][Full Text] [Related]
6. Effect of Vitamin D on Relapse-Free Survival in a Subgroup of Patients with p53 Protein-Positive Digestive Tract Cancer: A
Akutsu T; Okada S; Hirooka S; Ikegami M; Ohdaira H; Suzuki Y; Urashima M
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):406-413. PubMed ID: 31871108
[TBL] [Abstract][Full Text] [Related]
7. Genetic Variations in VDR could Modulate the Efficacy of Vitamin D3 Supplementation on Inflammatory Markers and Total Antioxidant Capacity among Breast Cancer Women: A Randomized Double Blind Controlled Trial.
Mohseni H; Amani R; Hosseini SA; Ekrami A; Ahmadzadeh A; Latifi SM
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2065-2072. PubMed ID: 31350967
[TBL] [Abstract][Full Text] [Related]
8. Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812).
Crew KD; Anderson GL; Hershman DL; Terry MB; Tehranifar P; Lew DL; Yee M; Brown EA; Kairouz SS; Kuwajerwala N; Bevers T; Doster JE; Zarwan C; Kruper L; Minasian LM; Ford L; Arun B; Neuhouser M; Goodman GE; Brown PH
Cancer Prev Res (Phila); 2019 Jul; 12(7):481-490. PubMed ID: 31138522
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
Wu X; Cheng J; Yang K
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
Mimpen M; Rolf L; Poelmans G; van den Ouweland J; Hupperts R; Damoiseaux J; Smolders J
PLoS One; 2021; 16(12):e0261097. PubMed ID: 34855907
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S;
Lancet Oncol; 2014 Feb; 15(2):143-55. PubMed ID: 24411639
[TBL] [Abstract][Full Text] [Related]
12. Effect of Vitamin D Supplements on Relapse or Death in a p53-Immunoreactive Subgroup With Digestive Tract Cancer: Post Hoc Analysis of the AMATERASU Randomized Clinical Trial.
Kanno K; Akutsu T; Ohdaira H; Suzuki Y; Urashima M
JAMA Netw Open; 2023 Aug; 6(8):e2328886. PubMed ID: 37606927
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.
De Smedt J; Van Kelst S; Boecxstaens V; Stas M; Bogaerts K; Vanderschueren D; Aura C; Vandenberghe K; Lambrechts D; Wolter P; Bechter O; Nikkels A; Strobbe T; Emri G; Marasigan V; Garmyn M
BMC Cancer; 2017 Aug; 17(1):562. PubMed ID: 28835228
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer.
Geredeli C; Artac M; Yildirim S; Inal A; Dede I; Guler T; Boruban MC; Koral L; Karaagac M; Zamani AG; Altinok T; Aribas O; Bozcuk H; Demirkazik A
Tumour Biol; 2015 Jun; 36(6):4279-85. PubMed ID: 25596702
[TBL] [Abstract][Full Text] [Related]
16. Effect of vitamin D3 supplementation and influence of BsmI polymorphism of the VDR gene of the inflammatory profile and oxidative stress in elderly women with vitamin D insufficiency: Vitamin D3 megadose reduces inflammatory markers.
de Medeiros Cavalcante IG; Silva AS; Costa MJ; Persuhn DC; Issa CT; de Luna Freire TL; da Conceição Rodrigues Gonçalves M
Exp Gerontol; 2015 Jun; 66():10-6. PubMed ID: 25827670
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial.
Grau MV; Baron JA; Sandler RS; Haile RW; Beach ML; Church TR; Heber D
J Natl Cancer Inst; 2003 Dec; 95(23):1765-71. PubMed ID: 14652238
[TBL] [Abstract][Full Text] [Related]
18. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the polymorphism of start codon and CDX2 site in vitamin D receptor gene and the effect of calcium supplementation on bone mineral density of postmenopausal women].
Zhang ZL; He JW; Huang QR; Qin YJ; Hu YQ; Li M; Zhang H; Liu YJ; Hu WW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):397-401. PubMed ID: 16883525
[TBL] [Abstract][Full Text] [Related]
20. Effect Modification of Vitamin D Supplementation by Histopathological Characteristics on Survival of Patients with Digestive Tract Cancer: Post Hoc Analysis of the AMATERASU Randomized Clinical Trial.
Yonaga H; Okada S; Akutsu T; Ohdaira H; Suzuki Y; Urashima M
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
